Tivantinib in Treating Patients With Metastatic Prostate Cancer

Clinical trial NCT01519414 · COMPLETED

Trial details

NCT number: NCT01519414
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hormone-Resistant Prostate Cancer Prostate Adenocarcinoma Recurrent Prostate Carcinoma Stage IV Prostate Cancer

Start date: 2012-01-11
Primary completion: 2015-08-18
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.